Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Urinary tract infection (lower) - women - Management
Which antibiotic should I prescribe for a woman with recurrent cystitis?

  • Follow local guidelines when available. Otherwise:
    • For empirical treatment, prescribe either:
      • Trimethoprim 200 mg twice daily, for 3 days, or
      • Nitrofurantoin 50 mg four times daily, or 100 mg (modified-release) twice daily, for 3 days.
    • If the woman has been treated with trimethoprim recently (up to a year previously), consider prescribing nitrofurantoin instead of trimethoprim.
Basis for recommendation

Choice of antibiotic

  • The reasons for preferring trimethoprim and nitrofurantoin as first-line options for treating cystitis are discussed in Choice of antibiotic.

Considering nitrofurantoin when trimethoprim has been used recently

  • Nitrofurantoin may be preferable for empirical prescribing when the woman has recently used trimethoprim because there is evidence that uropathogens are more likely to be resistant to trimethoprim if it has been used recently (up to the past year). The evidence is not clear enough to recommend precise thresholds of exposure.
  • Trimethoprim is not preferred when nitrofurantoin has previously been used because there is no evidence that previous treatment with nitrofurantoin increases the chance that future infections will be resistant organisms. Furthermore, laboratory studies find that nitrofurantoin-resistant Escherichia coli reproduce substantially less effectively than nitrofurantoin-sensitive E. coli (in other words, nitrofurantoin resistance imposes a high fitness cost on the organism) [Sandegren et al, 2008].

© NHS Institute for Innovation and Improvement